In Taiwan, drug sponsors are responsible for submitting applications for approval, ensuring clinical trial compliance with TFDA guidelines, and maintaining Good Manufacturing Practice (GMP) standards. They must also monitor the drug’s safety through post-market surveillance, submit Periodic Safety Update Reports (PSURs), and manage communications with the TFDA regarding any product changes or issues.